Should modern molecular testing be routinely available for the diagnosis of musculoskeletal infection?

Jerry Tsang; David W Eyre; Bridget Atkins; A Hamish R W Simpson

doi:10.1302/0301-620X.102B10.BJJ-2020-1496

Should modern molecular testing be routinely available for the diagnosis of musculoskeletal infection?

Jerry Tsang (Lead Author), David W Eyre, Bridget Atkins, A Hamish R W Simpson

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Journal	Bone and Joint Journal
DOIs	https://doi.org/10.1302/0301-620X.102B10.BJJ-2020-1496
Publication status	Published - 30 Sep 2020

Keywords

Musculoskeletal infection
Prosthetic joint infection
Fracture-related infection
Culture-negative infection
Molecular diagnostics
Metagenomic sequencing
Next-generation sequencing

Access to Document

10.1302/0301-620X.102B10.BJJ-2020-1496

Embargoed Document

Should modern molecular testing be routinely available 200716 (1)
Accepted author manuscript, 59.9 KB
Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)
Embargo ends: 30/09/21

Cite this

@article{19ea7d9cc6ce4ca9b30b1fad09baf0e6,

title = "Should modern molecular testing be routinely available for the diagnosis of musculoskeletal infection?",

keywords = "Musculoskeletal infection, Prosthetic joint infection, Fracture-related infection, Culture-negative infection, Molecular diagnostics, Metagenomic sequencing, Next-generation sequencing",

author = "Jerry Tsang and Eyre, {David W} and Bridget Atkins and Simpson, {A Hamish R W}",

year = "2020",

month = sep,

day = "30",

doi = "10.1302/0301-620X.102B10.BJJ-2020-1496",

language = "English",

journal = "Bone and Joint Journal",